Oranto Petroleum Limited

Nigeriaatlas-oranto.com

Oranto Petroleum Limited is a Nigerian independent oil and gas exploration and production company, part of the Atlas Oranto Petroleum group, one of Africa's largest privately-held, Africa-focused E&P firms by acreage. Founded in 1991 and headquartered in Abuja, it operates across multiple African countries, including Nigeria, Equatorial Guinea, Uganda, Liberia, São Tomé and Príncipe, Senegal, and others, holding interests in over 20 licenses encompassing onshore, shallow water, and deepwater blocks.

The company specializes in offshore drilling and maintains producing assets in Nigeria and Equatorial Guinea, with daily production around 18,000 barrels of oil. Recently, it sold a 75% stake in Block 3 offshore São Tomé and Príncipe to Petrobras, retaining 15% while Petrobras assumes operatorship.

Also known as Atlas Oranto Petroleum and Oranto Petroleum International Ltd.

Projects Oranto is involved in

chemXplore tracks 1 project involving Oranto, of which one is active.

Oranto's role on them: Investor / Financier.

1 FID / Sanctioned

1 new construction.

What moved recently
  • 9 July 2026 Petrobras Block 3 São Tomé and Príncipe Exploration Acquisition · FID / Sanctioned

Targeting: Crude oil (1), Natural gas (1)

Follow this project in chemXplore →

Latest news on Oranto

6 August 2026
Petrobras posts R$52.4bn Q2 2026 profit

Quarterly results bolstered by record own oil output, above-100% refinery utilization and higher derivative production, supporting cash generation and lower imports.

9 July 2026
Petrobras completes acquisition and operatorship of São Tomé and Príncipe Block 3

Consortium now set with operator at 75% and partners at 15% and 10%; move supports reserve replenishment through new-frontier exploration.

17 April 2026
Petrobras to acquire 75% and operatorship of Block 3 offshore São Tomé and Príncipe

Acquirer to take 75% and operatorship of Block 3 offshore São Tomé and Príncipe from Oranto. Post-deal: acquirer 75%, Oranto 15%, ANP‑STP 10%. Subject to regulatory approvals.